Nanotechnology-enabled targeted delivery of incretin therapies for the treatment of obesity and metabolic disorders
Obesity Medicine · 2026-05 · 61 · 100712
DOI: 10.1016/j.obmed.2026.100712 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesity Medicine, 2026-05. Verfasst von Daniel Ejim Uti und 6 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 217 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Uti, D. E., Egbung, J. E., Alum, E. U., Bawa, I., Agada, S. A., Ogbu, C. O., & Ugwu, O. P. (2026). Nanotechnology-enabled targeted delivery of incretin therapies for the treatment of obesity and metabolic disorders. Obesity Medicine, 61, 100712. https://doi.org/10.1016/j.obmed.2026.100712
Vancouver
Uti DE, Egbung JE, Alum EU, Bawa I, Agada SA, Ogbu CO, et al. Nanotechnology-enabled targeted delivery of incretin therapies for the treatment of obesity and metabolic disorders. Obesity Medicine. 2026;61:100712. doi:10.1016/j.obmed.2026.100712
BibTeX
@article{Uti2026,
author = {Uti, Daniel Ejim and Egbung, Josephine E. and Alum, Esther Ugo and Bawa, Inalegwu and Agada, Samuel Ali and Ogbu, Celestine O. and Ugwu, Okechukwu Paul-Chima},
title = {Nanotechnology-enabled targeted delivery of incretin therapies for the treatment of obesity and metabolic disorders},
journal = {Obesity Medicine},
year = {2026},
volume = {61},
pages = {100712},
doi = {10.1016/j.obmed.2026.100712}
}
EUVIMED